Signalling intentions… Tall Ships Race 2024 Turku, Finland

It’s an unfortunate truth very few currently available cancer therapies are capable of inducing durable complete responses in people with advanced solid cancers.

This is largely due to challenges such as tumour heterogeneity and acquired resistance or immune escape.

How can we change this situation for the better?

There are only so many targets to go around and existing modalities have their limits, thus what we need is some more innovative and creative strategies.

In this post we hone in on two such examples to explore what they and how they might make a difference…

To learn more from our latest oncology review and get a heads up on key cancer research insights, subscribers can log-in or you can click to gain access to BSB Premium Content.

This content is restricted to subscribers

Posted by